Rhythm Pharmaceuticals In...

NASDAQ: RYTM · Real-Time Price · USD
63.72
1.59 (2.56%)
At close: Jun 24, 2025, 3:59 PM
63.66
-0.09%
After-hours: Jun 24, 2025, 05:31 PM EDT

Rhythm Pharmaceuticals Statistics

Share Statistics

Rhythm Pharmaceuticals has 63.62M shares outstanding. The number of shares has increased by 3.69% in one year.

63.62M
3.69%
2.87%
99.99%
58.23M
10
n/a

Short Selling Information

The latest short interest is 4.78M, so 7.51% of the outstanding shares have been sold short.

4.78M
7.51%
9.75%
9.25

Valuation Ratios

The PE ratio is -13.1 and the forward PE ratio is -45.01. Rhythm Pharmaceuticals's PEG ratio is -0.42.

-13.1
-45.01
26.24
2.8
157.14
-29.98
-0.42
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Rhythm Pharmaceuticals.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 3.24, with a Debt / Equity ratio of 0.18.

3.24
3.08
0.18
-0.02
-0.03
-12.89

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$459,809.19
$-920,855.12
283
0.33
0.71

Taxes

346K
-0.13%

Stock Price Statistics

The stock price has increased by 49.05% in the last 52 weeks. The beta is 2.3, so Rhythm Pharmaceuticals's price volatility has been higher than the market average.

2.3
49.05%
62.34
56.65
52.89
724,138

Income Statement

In the last 12 months, Rhythm Pharmaceuticals had revenue of 130.13M and earned -260.6M in profits. Earnings per share was -4.21.

130.13M
116.76M
-265.5M
-260.6M
-238.09M
-239.65M
-4.21
Full Income Statement

Balance Sheet

The company has 89.14M in cash and 3.94M in debt, giving a net cash position of 85.2M.

89.14M
3.94M
85.2M
-1.16B
386.69M
257.46M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -113.88M and capital expenditures 0, giving a free cash flow of -113.88M.

-113.88M
n/a
-113.88M
-1.87
Full Cash Flow Statement

Margins

Gross margin is 89.73%, with operating and profit margins of -204.04% and -200.27%.

89.73%
-204.04%
-200%
-200.27%
-182.97%
-204.04%
-87.51%

Dividends & Yields

RYTM does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for RYTM is $73.5, which is 15.3% higher than the current price. The consensus rating is "Strong Buy".

$73.5
15.3%
Strong Buy
12
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

6.06
4